1.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MM03, NCT01010243
|
|
2.
|
Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: MEL001, NCT01614301
|
|
3.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 18 to 85 Sponsor: Other Protocol IDs: CLIN-005-08S, NCT00780234
|
|
4.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention, Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2012-03152, INC07-10-01, N01CN35153, N01CN35159, NCT00951379
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 75 Sponsor: Other Protocol IDs: 2011.097, NCT01655719
|
|
6.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: STU 072012-036, NCT01838317
|
|
7.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: SCCC-02208, SCCC-02208, NCT00867126
|
|
8.
|
Phase: Phase I Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CCCWFU 97409, NCI-2009-01452, NCT01151670
|